Compounds > dronabinol
Page last updated: 2024-08-21

dronabinol and 2019 Novel Coronavirus Disease

dronabinol has been researched along with 2019 Novel Coronavirus Disease in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's12 (100.00)2.80

Authors

AuthorsStudies
Delnevo, CD; Gratale, SK; Jeong, M; O'Connor, RJ; Steinberg, MB; Wackowski, OA1
Bastiani, MF; da Silva Moreira, IC; do Nascimento, CA; Hahn, RZ; Linden, R; Lizot, LLF; Meireles, YF; Schneider, A; Viana, MF1
Kovalchuk, I; Kovalchuk, O; Pryimak, N; Suryavanshi, SV; Zaiachuk, M1
Akhoundzadeh, D; Gresnigt, FMJ; Kamali, P; van den Bogaard, B1
Deimel, D; Firk, C; Fleißner, S; Hees, N; Scherbaum, N; Stöver, H1
Chu, HW; Gupta, A; Hume, PS; Petrache, I; Rivera, T; Schweitzer, KS1
Blagev, DP; Callahan, SJ; Collingridge, DS; Dean, NC; Guidry, DW; Harris, D; Lanspa, MJ1
Cai, G; F K Alghetaa, H; Miranda, K; Mohammed, A; Nagarkatti, M; Nagarkatti, P; P Singh, N; Putluri, N; Wilson, K1
Kriikku, P; Mariottini, C; Ojanperä, I1
Abu-Izneid, T; Almalki, FA; Alqahtani, AM; Bader, A; Berredjem, M; Elsharkawy, ER; Hadda, TB; Khalid, S1
Cho, KH; Choi, P; Ham, J; Kim, T; Lee, J; Park, JG; Raj, V1
Aguirre Dávila, L; Guizzaro, L; Koch, A; Lasch, F; Müller-Vahl, K1

Reviews

1 review(s) available for dronabinol and 2019 Novel Coronavirus Disease

ArticleYear
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Current pharmaceutical design, 2021, Volume: 27, Issue:13

    Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; China; COVID-19; Dronabinol; Female; Greece; Horses; Humans; SARS-CoV-2

2021

Other Studies

11 other study(ies) available for dronabinol and 2019 Novel Coronavirus Disease

ArticleYear
Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest.
    Tobacco control, 2023, Volume: 32, Issue:e2

    Topics: Acetates; Adult; COVID-19; Dronabinol; Electronic Nicotine Delivery Systems; Humans; Lung Injury; Smokers; Vaping; Vitamin E

2023
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
    Chemosphere, 2022, Volume: 302

    Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical

2022
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
    Cells, 2022, 04-20, Volume: 11, Issue:9

    Topics: Cannabidiol; Cannabinoids; COVID-19; Cytokine Release Syndrome; Cytokines; Dronabinol; Humans; Inflammasomes; Lipopolysaccharides; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; STAT3 Transcription Factor; TYK2 Kinase

2022
[Impact of the COVID-19 pandemic on recreational drug intoxications].
    Nederlands tijdschrift voor geneeskunde, 2022, 07-06, Volume: 166

    Topics: Adolescent; Cocaine; Communicable Disease Control; COVID-19; Dronabinol; Emergency Service, Hospital; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Retrospective Studies; Sodium Oxybate; Substance-Related Disorders

2022
Substance Use and Mental Health during the First COVID-19 Lockdown in Germany: Results of a Cross-Sectional Survey.
    International journal of environmental research and public health, 2022, 10-06, Volume: 19, Issue:19

    Topics: Communicable Disease Control; COVID-19; Cross-Sectional Studies; Dronabinol; Germany; Humans; Mental Health; Nicotine; Pandemics; SARS-CoV-2; Substance-Related Disorders

2022
Pathogenesis of E-Cigarette Vaping Product Use-Associated Lung Injury (EVALI).
    Comprehensive Physiology, 2023, 03-30, Volume: 13, Issue:2

    Topics: COVID-19; Dronabinol; Electronic Nicotine Delivery Systems; Humans; Lung Injury; United States; Vaping

2023
Diagnosing EVALI in the Time of COVID-19.
    Chest, 2020, Volume: 158, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Betacoronavirus; Bronchoscopy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Dronabinol; Electronic Nicotine Delivery Systems; Female; Humans; Influenza, Human; Intensive Care Units; Lung; Lung Injury; Male; Middle Aged; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Vaping; Young Adult

2020
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    International journal of molecular sciences, 2020, Aug-28, Volume: 21, Issue:17

    Topics: Aged; Animals; Apoptosis; Betacoronavirus; Bronchoalveolar Lavage Fluid; Cannabinoid Receptor Agonists; Coronavirus Infections; COVID-19; Cytokines; Dronabinol; Enterotoxins; Female; Humans; Lung; Male; Mice; Mice, Inbred C3H; MicroRNAs; Middle Aged; Pandemics; Pneumonia; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Signal Transduction

2020
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland.
    Drug testing and analysis, 2021, Volume: 13, Issue:4

    Topics: Amphetamine; Analgesics, Opioid; Autopsy; Buprenorphine; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; COVID-19; Dronabinol; Finland; Forensic Toxicology; Harm Reduction; Humans; Illicit Drugs; Substance-Related Disorders

2021
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.
    International journal of biological macromolecules, 2021, Jan-31, Volume: 168

    Topics: Antiviral Agents; Cannabidiol; Cannabinoids; Computer Simulation; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Dronabinol; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Ligands; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; Protease Inhibitors; SARS-CoV-2

2021
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
    Pharmaceutical statistics, 2021, Volume: 20, Issue:3

    Topics: Cannabidiol; Computer Simulation; COVID-19; Data Interpretation, Statistical; Dronabinol; Drug Combinations; Endpoint Determination; Humans; Mental Health; Physical Distancing; Randomized Controlled Trials as Topic; Research Design; Sample Size; Severity of Illness Index; Tic Disorders; Tics; Time Factors; Tourette Syndrome; Treatment Outcome

2021